Nektar Therapeutics (NKTR): Q4 EPS of -$0.33 beats by $0.14. Revenue of $15.8M (-65% Y/Y) beats...

|About: Nektar Therapeutics (NKTR)|By:, SA News Editor
Nektar Therapeutics (NKTR): Q4 EPS of -$0.33 beats by $0.14. Revenue of $15.8M (-65% Y/Y) beats by $3M. Shares +1.9% AH. (PR)